Developing senolytic therapies targeting aging

https://www.rubedolife.com

Organization Description

Rubedo Life Sciences are developing small molecules to clear senescent cells from aged or pathological tissues, supporting tissue regeneration and restoring organ function. They seek to develop novel pharmacological treatments that are non-toxic and selective for senescent cells.

Team

Marco Quarta, Ph.D.

Rubedo Life Sciences - CEO

Related Topics

Cellular Senescence is one of the proposed reasons we age.

Why we Age: Cellular Senescence

As your body ages, more of your cells become senescent. Senescent cells do not divide or support the tissues of which they are part; instead, they emit potentially harmful chemical signals, collectively known as the senescence-associated secretory phenotype (SASP), which encourages nearby cells to enter the same senescent state. Their presence causes many problems: they degrade tissue function, increase chronic inflammation, and can even eventually raise the risk of cancer and other age-related ...
Read More